Biologics CDMO Market Size & Share Analysis - Mordor Intelligence

The Biologics CDMO Market is expected to reach USD 18.17 billion in 2024 and grow at a …

CouponFollow Extension

51%
OFF

The Biologics Contract Development And Manufacturing …

1 week from now

to register a CAGR of 11.51% during 2023 - 2028 - Market Size, Share, Forecasts, and Trends …

globenewswire.com

43%
OFF

Global Biologics CDMO Market Size, Trends & Forecast I BIS …

1 week from now

Global biologics CDMO market is expected to grow at a CAGR of 15.43% during the forecast …

bisresearch.com

FAQs about Biologics CDMO Market Size & Share Analysis - Mordor Intelligence Coupon?

How big is the biologics CDMO market?

The Biologics CDMO Market size is estimated at USD 18.17 billion in 2024, and is expected to reach USD 30.45 billion by 2029, growing at a CAGR of 10.87% during the forecast period (2024-2029). The global pharmaceutical industry is growing exponentially, driven by global economic growth, a growing and aging population, and new product launches. ...

What is the biologics CDMO share report?

Biologics Cdmo share report includes a market forecast to 2028 and historical overview. Get a sample of this industry share analysis as a free report PDF download. The biologics contract development and manufacturing organization (CDMO) market is highly concentrated, with close to half of the market being dominated by a few players. ...

What companies are in the biologics CDMO market?

Boehringer Ingelheim Group, Wuxi Biologics (Cayman) Inc., Samsung Biologics, Lonza Group Ltd and Fujifilm Diosynth Biotechnologies USA Inc. are the major companies operating in the Biologics CDMO Market. Which is the fastest growing region in Biologics CDMO Market? ...

Who dominates the biologics contract development & manufacturing organization (CDMO) market?

The biologics contract development and manufacturing organization (CDMO) market is highly concentrated, with close to half of the market being dominated by a few players. In 2021, major players, such as Catalent, Boehringer Ingelheim Group, Lonza Group, and Samsung Biologics, together accounted for more than 30.1% of the market studied. ...

Where is the biologics CDMO industry located?

North America is one of the major markets for the biologics CDMO industry, owing to the presence of two major economies, such as the United States and Canada. The United States is home to one of the major pharmaceutical industries in the world and commands a significant share of the industry revenue. ...

What is the role of CDMOs in biotechnology?

Additionally, pharmaceutical companies’ increasing dependence on biologics CDMOs is expanding the capacities in this category. For example, major participants, such as Lonza, WuXi Biologics, and Samsung Biologics, are likely to raise their mammalian cell culture capacity by about 30–40% in this decade. ...